It would seem to me that the oft repeated (in various investor presentations) 1H 2018 timeline for the reporting of results is well and truly not achievable.
Announced 31-08-2017: First patient dosing.
Announced 07-02-2017: Promising early results for first cohort and go ahead for increased dosing of next cohort.
That took over five months.
No further news in the three and a half months since. No announcement of proceeding to the third cohort. No announcement of any delay, but with only six weeks to go before the end of 1H 2018 and the trial nowhere near complete, there has surely been some sort of delay.
Vienna meeting?
Phase 1B timeline
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.001(0.98%) |
Mkt cap ! $376.9M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.2¢ | 4.9¢ | $1.339M | 26.44M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 246695 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 738936 | 14 |
View Market Depth
| Last trade - 15.53pm 03/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |